How should I calculate the insulin dose for Mixtard 30/70 (30% regular insulin, 70% NPH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Calculating Insulin Dose for Mixtard 30/70

For Mixtard 30/70 (premixed 30% regular/70% NPH insulin), start with 10 units per day or 0.1–0.2 units/kg/day administered twice daily, with approximately two-thirds of the total dose given before breakfast and one-third before dinner. 1, 2

Initial Dosing Strategy

Starting Dose Calculation

  • Begin with 10 units per day total OR calculate 0.1–0.2 units/kg/day based on body weight 1, 2
  • For twice-daily premixed insulin regimens like Mixtard 30/70, distribute the total daily dose as:
    • Two-thirds (≈67%) before breakfast 1
    • One-third (≈33%) before dinner 1

Example: For a 70 kg patient starting at 0.15 units/kg/day:

  • Total daily dose = 70 kg × 0.15 = 10.5 units/day
  • Morning dose = 7 units
  • Evening dose = 3–4 units

When to Use Higher Starting Doses

  • If presenting with A1C >10% (>86 mmol/mol) or blood glucose ≥300 mg/dL (≥16.7 mmol/L), consider starting at the higher end of the dosing range (0.2 units/kg/day) 1, 2
  • Symptomatic hyperglycemia warrants more aggressive initial dosing 1

Titration Algorithm

Systematic Dose Adjustment

  • Increase by 2 units every 3 days until fasting plasma glucose (FPG) goal is achieved without hypoglycemia 1, 2
  • Set individualized FPG targets before beginning titration 1, 2
  • Adjust each injection (morning and evening) separately based on glucose patterns 1

Hypoglycemia Management

  • If hypoglycemia occurs without obvious cause, reduce the corresponding dose by 10–20% 1, 2
  • Prescribe glucagon for emergency treatment when initiating insulin therapy 2
  • Monitor for both aware and unaware hypoglycemia 1

Critical Considerations for Mixtard 30/70

Advantages of Premixed Formulations

  • Mixtard 30/70 eliminates the need for patients to self-mix insulins, improving convenience and reducing dosing errors 3
  • Studies demonstrate that patients poorly controlled on various self-mixed ratios can be safely transferred to 70/30 premixed insulin, often dose-for-dose 3
  • The fixed ratio provides both prandial coverage (30% regular) and basal coverage (70% NPH) in a single injection 4

Timing and Administration

  • Administer before meals (typically breakfast and dinner) 5, 6
  • The 30% regular insulin component covers the meal, while the 70% NPH provides intermediate-acting coverage 4
  • Never change insulin type, strength, or manufacturer without medical supervision, as this may require dose adjustments 7

Monitoring and Reassessment

Regular Evaluation Points

  • Assess adequacy at every visit (every 3–6 months minimum) to avoid therapeutic inertia 1, 2
  • Monitor for signs of over-basalization: elevated bedtime-to-morning glucose differential, hypoglycemia, or high glucose variability 1
  • Track A1C levels; if A1C remains above goal despite adequate titration, consider intensifying therapy 1

When Mixtard 30/70 May Be Insufficient

  • If A1C remains elevated despite optimal twice-daily dosing, consider adding GLP-1 receptor agonists or transitioning to a basal-bolus regimen 1, 2
  • Evidence shows that 70/30 insulin algorithms provide superior glycemic control compared to sliding-scale insulin alone 8
  • For patients requiring more flexibility, separate basal and prandial insulin components allow independent adjustment 1

Common Pitfalls to Avoid

  • Do not use sliding-scale insulin as the primary regimen—scheduled insulin dosing with Mixtard 30/70 is more effective 8
  • Avoid changing syringe type or brand without adjusting for potential differences in dead space between manufacturers 7
  • Always use U-100 syringes with Mixtard 30/70 to prevent dosing errors; using the wrong syringe concentration can cause serious hypo- or hyperglycemia 7
  • Do not delay dose adjustments—titrate systematically every 3 days rather than waiting weeks between changes 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.